← All team
Anthony Liveris
Team / Management / Anthony Liveris
01 / 04 Management

Anthony Liveris

Chief Executive Officer

Anthony leads Proto Axiom, an Australian biotechnology company builder focused on translating breakthrough science into enduring businesses. He previously co-founded Applecart, a New York-based data and technology company backed by Blackstone.

Section
Management · Board
At Proto Axiom
Since 2021 · Founder
Based
Sydney
Expertise Founder-operatorCapital marketsGovernment & policy
Biography

Anthony Liveris is Chief Executive Officer of Proto Axiom, an Australian biotechnology company builder focused on translating breakthrough science into enduring businesses. Proto Axiom brings together capital, scientific expertise and operational support to establish and grow companies, with incubated assets including Endo Axiom, Onyx Axiom, Flo Axiom, SWAN Genomics and JumpStart Fertility.

Proto Axiom has also established the Women’s Health Foundry, a national initiative to accelerate the translation and commercialisation of research in women’s health.

Anthony previously co-founded Applecart, a New York-based data and technology company backed by Blackstone. His experience spans entrepreneurship and public policy, including roles with former Australian Prime Minister Malcolm Turnbull, the Tony Blair Institute, and several U.S. presidential campaigns.

He serves as Chairman of the St Vincent’s Hospital Discovery and Innovation Fund, supporting the translation of medical research into patient impact, and as a member of the La Trobe Institute for Molecular Science (LIMS) Advisory Board.

Anthony holds a Master of Public Policy from the Blavatnik School of Government at the University of Oxford and a Bachelor of Arts from the University of Pennsylvania.

The ambition is straightforward: four CSL-scale companies built from Australian science in twenty years. Everything we do is in service of that arithmetic.

From the 2026 portfolio letter
Selected affiliations
  • Chair St Vincent’s Hospital Discovery and Innovation Fund
  • Advisory Board Member La Trobe Institute for Molecular Science (LIMS)